Noticias de BJDX_US

Noticias del mercado

Últimas noticias sobre BJDX_US — 149 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BJDX_US ✕ 149 resultados
20/04/2026 BJDX_US — Meyka ES ← EN
¿Por qué las acciones de Bluejay Diagnostics, Inc. (BJDX) están bajas hoy?

Why Is Bluejay Diagnostics, Inc. (BJDX) Stock Down Today?

20/04/2026 BJDX_US — sonla.gov.vn
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Social Flow Trades
20/04/2026 BJDX_US — syt.laocai.gov.vn ES ← EN
¿Son riesgosas las acciones de Bluejay Diag (BJDX) (ligera caída)? 2026-04-20 - Social Flow Trades
20/04/2026 BJDX_US — laocai.gov.vn
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Crowd Sentiment Stocks
20/04/2026 BJDX_US — tayninh.gov.vn
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Crowd Sentiment Stocks
20/04/2026 BJDX_US — newser.com
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Stock Entry Points
20/04/2026 BJDX_US — newsline.com
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Stop Hunt
20/04/2026 BJDX_US — Newser
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Momentum Surge Alerts
20/04/2026 BJDX_US — Stock Titan
Board seeks flexible reverse split, plan increase at Bluejay Diagnostics (NASDAQ: BJDX)
20/04/2026 BJDX_US — Newser
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Tick Index
20/04/2026 BJDX_US — Newser
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Breakout Watch
20/04/2026 BJDX_US — newser.com
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20 - Stock Entry Points
13/04/2026 BJDX_US — Bitget ES ← EN
Valores de bjdx: descripción general de Bluejay Diagnostics
07/04/2026 BJDX_US — The Manila Times
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
07/04/2026 BJDX_US — Yahoo Finance
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
07/04/2026 BJDX_US — TradingView
Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
07/04/2026 BJDX_US — Stock Titan
Bluejay nears finish line in sepsis test study with 624 patients
07/04/2026 BJDX_US — Stock Titan
SYMON-II sepsis trial nears full enrollment at Bluejay (NASDAQ: BJDX)
07/04/2026 BJDX_US — TipRanks
Bluejay Nears Completion of Pivotal SYMON-II Sepsis Trial
07/04/2026 BJDX_US — Minichart ES ← EN
Bluejay Diagnostics se acerca a la finalización del ensayo clínico SYMON-II con 624 inscripciones de pacientes para la prueba de sepsis Symphony IL-6

Página 7 de 8

keyboard_arrow_up